Italia markets open in 5 hours 1 minute

Becton, Dickinson and Company (BDX)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
257,85+8,03 (+3,21%)
Alla chiusura: 4:00PM EDT

257,80 -0,05 (-0,02%)
Dopo ore: 7:44PM EDT

Becton, Dickinson and Company

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
201 847 6800
http://www.bd.com

Settore/iHealthcare
SettoreMedical Instruments & Supplies
Impiegati a tempo pieno70.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Vincent A. ForlenzaExec. Chairman2,51M40,3M1953
Mr. Thomas E. Polen Jr.Pres, CEO & Director2,11M1,72M1973
Mr. Christopher R. ReidyExec. VP, CFO & Chief Admin. Officer1,4MN/D1957
Mr. Samrat S. KhichiExec. VP of Regulatory & Gov. Affairs and Gen. Counsel2,19MN/D1967
Mr. Alberto MasExec. VP & Pres of the Medical Segment1,15M1,64M1961
Mr. Thomas J. SpoerelVP, Controller & Chief Accounting OfficerN/DN/D1978
Dr. John A. DeFordExec. VP of R&D and CTON/DN/D1962
Jerry FlaszExec. VP of Global Services & Chief Information OfficerN/DN/DN/D
Ms. Monique N. DoleckiSr. VP of Investor RelationsN/DN/DN/D
Michelle QuinnSr. VP and Chief Ethics & Compliance OfficerN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2020 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Governance aziendale

L'ISS Governance QualityScore di Becton, Dickinson and Company al 1 aprile 2021 è 9. I criteri di valutazione fondamentali sono revisione: 5; Consiglio di Amministrazione: 7; diritti degli azionisti: 10; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.